"The FDA approval of Optune Pax marks the first new treatment in decades for people living with locally advanced pancreatic ...

The Life Science division of Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials, today announced the launch of its Lyophilized NGS ...

And that was also presented at ASH 2025 and also a very, very strong data set. I should mention that BI-1808 that was monotherapy, single-agent therapy. Then, we also started our Phase IIa trial ...

That track record is fueling a concentrated push among clinical-stage oncology companies toward registration-directed study designs in high-unmet-need tumor types, as demonstrated by Oncolytics ...

USA News Group News Commentary, The global oncology market is on track to nearly triple in value over the next decade, growing from $279.98 billion in 2026 to an estimated $748.17 billion by 2035[1].

Mitochondria possess their own mRNA translation system, mediated by specialized mitoribosomes. Dysregulation of mitochondrial translation disrupts metabolic homeostasis and is linked to various ...

Thank you, and welcome to our Q4 and fiscal year 2025 results call. With me today, we have Harish Shantharam, our CFO, as well as our CMO, Dr. Barbara Klencke. As many of you know, after joining in an ...

A proposed function of TADs is to contribute to gene regulation by promoting chromatin interactions within a TAD and by suppressing interactions between TADs. Here, we directly probe the ...

Prof. Dr. Bankole Johnson, DSc, MD, Offers Advanced Regenerative Protocols to Support Neurological Wellness and ...

SHENZHEN, GUANGDONG, CHINA, February 7, 2026 /EINPresswire.com/ -- As the global new energy industry continues to ...

Q4 2025 Earnings Call February 26, 2026 4:30 PM ESTCompany ParticipantsMike Brophy - Chief Financial OfficerSteve Chapman - CEO ...

ZHUHAI, GUANGDONG, CHINA, January 21, 2026 /EINPresswire.com/ -- The global LED lighting and signage industry continues ...